A Registry for People With T-cell Lymphoma

Clinical trial NCT05978141 · RECRUITING

Trial details

NCT number: NCT05978141
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Study type: OBSERVATIONAL

T-cell Lymphoma NK-Cell Lymphoma T-cell Prolymphocytic Leukemia T-cell Large Granular Lymphocytic Leukemia Chronic Lymphoproliferative Disorder of NK Cells Aggressive NK-cell Leukemia Systemic Epstein-Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood (Disorder)Systemic Epstein Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood Chronic Active EBV Infection of T-and NK-Cell Type, Systemic Form Hydroa Vacciniforme-Like Lymphoproliferative Disorder Adult T-cell Leukemia/Lymphoma Extranodal NK/T-cell Lymphoma, Nasal Type

Start date: 2023-07-27
Primary completion: 2030-07-27
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.